In vitro–in vivo and pharmacokinetic evaluation of solid lipid nanoparticles of furosemide using Gastroplus™-Reference-Cited by-同舟云学术

In vitro–in vivo and pharmacokinetic evaluation of solid lipid nanoparticles of furosemide using Gastroplus™

Published:2017 Issue:53 Volume:7 Page:33314-33326
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Ali Hasan¹²³⁴,Prasad Verma Priya Ranjan¹²³⁴,Dubey Sunil Kumar⁵⁶⁷⁴,Venkatesan Jayachandran⁸⁹¹⁰,Seo Youngwan¹¹¹²¹³¹⁰,Kim Se-Kwon⁸⁹¹⁰¹¹¹²^ORCID,Singh Sandeep Kumar¹²³⁴¹⁴^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences and Technology

2. Birla Institute of Technology

3. Ranchi-835215

4. India

5. Department of Pharmacy

6. Birla Institute of Technology and Science

7. Pilani

8. Kolmar Korea Co., Ltd.

9. Seoul

10. Republic of Korea

11. Department of Marine Life Sciences

12. Korean Maritime and Ocean University

13. Busan 49112

14. Marine Bioprocess Research Centre and Department of Marine Bio-convergence Science

Abstract

In this work, we conducted pharmacokinetic studies and established the in vitro and in vivo correlation (IVIVC) of furosemide (FRS) loaded solid lipid nanoparticles (FSLN).

Funder

University Grants Commission

National Research Foundation of Korea

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/RA/C7RA04038E

Reference52 articles.

1. Diverse approaches for the enhancement of oral drug bioavailability

2. Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization